Mycophenolate Mofetil
This immunosuppressant medication is used after organ transplantation to prevent the body from rejecting the new organ. It works by reducing the activity of white blood cells that would otherwise attack the transplanted tissue, and is usually taken alongside other anti-rejection drugs.
Molekularmasse
433,5000 g/mol
LogP
3,20
TPSA
94,50 Ų
Lipinski-Regel der Fünf
Bestanden
Therapeutische Bereiche
Wirkmechanismus
Suppresses the immune system by inhibiting T-cell activation, lymphocyte proliferation, or cytokine production. This prevents immune-mediated tissue damage and graft rejection.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Suppresses the immune system by inhibiting T-cell activation, lymphocyte proliferation, or cytokine production. This prevents immune-mediated tissue damage and graft rejection.
2D-Struktur
Cite this structure
Embed this structure
SMILES
COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2
InChI
InChI=1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+
Molecular Formula
C23H31NO7
HBD / HBA
1 / 8
Rotierbare Bindungen
10
Schwere Atome
31
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Häufig gestellte Fragen
This immunosuppressant medication is used after organ transplantation to prevent the body from rejecting the new organ. It works by reducing the activity of white blood cells that would otherwise attack the transplanted tissue, and is usually taken alongside other anti-rejection drugs.
Suppresses the immune system by inhibiting T-cell activation, lymphocyte proliferation, or cytokine production. This prevents immune-mediated tissue damage and graft rejection.
Yes, Mycophenolate Mofetil is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1456. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 5281078. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="mycophenolate-mofetil"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/mycophenolate-mofetil/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/mycophenolate-mofetil/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/mycophenolate-mofetil/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="mycophenolate-mofetil"></drugfyi-drug>